Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, metaanalýza, práce podpořená grantem, přehledy, systematický přehled
Grantová podpora
129920
Canadian Institutes of Health Research - International
PubMed
29807048
DOI
10.1016/j.pcad.2018.05.004
PII: S0033-0620(18)30094-X
Knihovny.cz E-zdroje
- Klíčová slova
- Cardiometabolic risk, Cardiovascular risk, Dietary Portfolio, Dietary pattern, LDL-cholesterol, Nuts, Plant protein, Plant sterols, Portfolio diet, Systematic review and meta-analysis, Viscous fibre,
- MeSH
- chování snižující riziko * MeSH
- dieta vegetariánská * MeSH
- kardiovaskulární nemoci krev mortalita patofyziologie prevence a kontrola MeSH
- krevní tlak MeSH
- lidé MeSH
- lipidy krev MeSH
- mediátory zánětu krev MeSH
- medicína založená na důkazech MeSH
- nutriční hodnota MeSH
- nutriční stav MeSH
- ochranné faktory MeSH
- prognóza MeSH
- randomizované kontrolované studie jako téma MeSH
- rizikové faktory MeSH
- stravovací zvyklosti * MeSH
- tělesná hmotnost MeSH
- zdravá strava * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- systematický přehled MeSH
- Názvy látek
- lipidy MeSH
- mediátory zánětu MeSH
BACKGROUND: The evidence for the Portfolio dietary pattern, a plant-based dietary pattern that combines recognized cholesterol-lowering foods (nuts, plant protein, viscous fibre, plant sterols), has not been summarized. OBJECTIVE: To update the European Association for the Study of Diabetes clinical practice guidelines for nutrition therapy, we conducted a systematic review and meta-analysis of controlled trials using GRADE of the effect of the Portfolio dietary pattern on the primary therapeutic lipid target for cardiovascular disease prevention, low-density lipoprotein cholesterol (LDL-C), and other established cardiometabolic risk factors. METHODS: We searched MEDLINE, EMBASE, and The Cochrane Library through April 19, 2018. We included controlled trials ≥ 3-weeks assessing the effect of the Portfolio dietary pattern on cardiometabolic risk factors compared with an energy-matched control diet free of Portfolio dietary pattern components. Two independent reviewers extracted data and assessed risk of bias. The primary outcome was LDL-C. Data were pooled using the generic inverse-variance method and expressed as mean differences (MDs) with 95% confidence intervals (CIs). Heterogeneity was assessed (Cochran Q statistic) and quantified (I2-statistic). GRADE assessed the certainty of the evidence. RESULTS: Eligibility criteria were met by 7 trial comparisons in 439 participants with hyperlipidemia, in which the Portfolio dietary pattern was given on a background of a National Cholesterol Education Program (NCEP) Step II diet. The combination of a portfolio dietary pattern and NCEP Step II diet significantly reduced the primary outcome LDL-C by ~17% (MD, -0.73 mmol/L, [95% CI, -0.89 to -0.56 mmol/L]) as well as non-high-density lipoprotein cholesterol, apolipoprotein B, total cholesterol, triglycerides, systolic and diastolic blood pressure, C-reactive protein, and estimated 10-year coronary heart disease (CHD) risk, compared with an NCEP Step 2 diet alone (p < 0.05). There was no effect on high-density lipoprotein cholesterol or body weight. The certainty of the evidence was high for LDL-cholesterol and most lipid outcomes and moderate for all others outcomes. CONCLUSIONS: Current evidence demonstrates that the Portfolio dietary pattern leads to clinically meaningful improvements in LDL-C as well as other established cardiometabolic risk factors and estimated 10-year CHD risk.
Citace poskytuje Crossref.org